期刊文献+

MMP-3和OPN水平与绝经后骨质疏松症的相关性 被引量:3

下载PDF
导出
摘要 目的:探讨血清基质金属蛋白酶-3(MMP-3)和骨桥蛋白(OPN)水平及其与绝经后骨质疏松症的关系。方法:将120名绝经后妇女用酶联免疫吸附试验测定血清MMP-3、骨保护蛋白(OPG)、骨保护蛋白配体(OPGL)和骨桥蛋白(OPN),计算OPN/MMP-3比值,用双能X线吸收法(DEXA)测定腰椎正位,股骨颈,华氏区和大粗隆的骨密度(BMD)。按WHO标准,将绝经后妇女分为骨密度正常、低骨量和骨质疏松3组。结果:①骨质疏松组中血清OPN数值(56±20)ng/mL明显高于正常组(26±11)ng/mL,MMP-3的数值(153±121)ng/mL高于正常组(125±101)ng/mL。②骨质疏松组中血清MMP-3、OPN和OPN/MMP-3比值与腰椎正位、股骨颈和Ward’s三角骨密度、血清OPGL数值存在明显负相关性(P<0.05),和OPG数值存在明显正相关性(P<0.05)。结论:血清OPN水平和OPN/MMP-3比值升高可能为绝经后骨质疏松症伴随骨代谢转换过程增快的表现。
出处 《中国民族民间医药》 2011年第21期42-43,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
基金 湖北省卫生厅青年科技人才项目(QJX2010-48) 武汉市青年科技晨光计划项目(200950431215) 武汉市卫生局临床医学项目(WZ10C02)
  • 相关文献

参考文献1

二级参考文献26

  • 1金亚,廖二元,罗湘杭,周后德.雌激素诱导MG63细胞MT1MMP蛋白表达的信号转导通路[J].中华内分泌代谢杂志,2004,20(4):357-359. 被引量:3
  • 2廖二元,伍贤平,黄干,邓小戈,张红,朱旭萍,唐炜立.用三次回归模型建立女性多骨骼部位骨密度参考数据库及其应用评价[J].中华内分泌代谢杂志,2003,19(4):282-286. 被引量:18
  • 3郭丽娟,罗湘杭,伍贤平,谢辉,周后德,张红,曹行之,廖二元.绝经后妇女血清基质金属蛋白酶-1、-2和组织金属蛋白酶抑制因子-1水平及其与骨密度及骨转换生化指标的关系[J].中华医学杂志,2005,85(11):734-737. 被引量:12
  • 4谢辉,袁凌青,罗湘杭,郭丽娟,肖新华,周后德,王敏,伍贤平,廖二元.地塞米松抑制MG-63成骨样细胞TIMP-1的分泌[J].中华内分泌代谢杂志,2006,22(3):243-244. 被引量:1
  • 5Altman RD. Criteria for classification of clinical osteoarthritis. J Rheumatol, 1991,27 (Suppl) : 10-12.
  • 6Rifas L, Fausto A, Scott M J, et al. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology, 1994,134:213-221.
  • 7Filanti C, Dickson GR, Di Martino D, et al. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res, 2000,15:2154-2168.
  • 8Garnero P, Somay-Rendu E, Claustrat B, et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res, 2000, 15:1526-1536.
  • 9Hill PA, Murphy G, Docherty AJ, et al. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci, 1994,107:3055-3064.
  • 10Kusano K, Miyaura C, Inada M, et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13 ) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology, 1998,139 : 1338-1345.

共引文献7

同被引文献46

  • 1张永红,温进坤,韩梅.抗骨桥蛋白抗体防治大鼠动脉粥样硬化的研究[J].中国老年学杂志,2007,27(1):38-40. 被引量:4
  • 2许勇,杨桦,乔建瓯,李西华,严兰珍,王龙,徐国江,费俭,傅继粱,王铸钢.骨保护素(Opg)基因敲除小鼠发生高转换型骨质疏松和动脉钙化(英文)[J].生物化学与生物物理进展,2007,34(3):260-266. 被引量:26
  • 3Lidgren L. The bone and joint decade and the global economic and healthcare burden of musculoskeletal disease[J]. J Rheumatol Suppl, 2003, 67(67): 4-5.
  • 4Oshima Y, Matsuda K, Yoshida A, et al. Localization of estrogen receptors alpha and beta in the articular surface of the rat femur[J]. Acta Histochem Cytochem, 2007, 40(1): 27-34.
  • 5Roman-Bias JA, Stokes DG, Jimenez SA. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes[J]. Osteoarthritis Cartilage, 2007, 15(12): 1367-1377.
  • 6Sowers MR, Mcconnell D, Jannausch M, et al. Estradiol and its metabolites and their association with knee osteoarthritis[J]. Arthritis Rheum, 2006, 54(8): 2481-2487.
  • 7Kusano K, Miyaura C, Inada M, et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption[J]. Endocrinology, 1998, 139(3): 1338-1345.
  • 8Behets C, Williams JM, Chappard D, et al. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior eruciate ligament deficiency[J]. J Bone Miner Res, 2004, 19(11): 1821-1826.
  • 9Fujikawa Y, Sabokbar A, Neale SD, et al. The effect of macrophage- colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells[J]. Bone, 2001, 28(3): 261-267.
  • 10Karsdal MA, Tanko LB, Riis B J, et al. Calcitonin is involved in cartilage homeostasis:is calcitonin atreatment for OA? [J]. Osteoarthritis Cartilage, 2006, 14(7): 617-624.

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部